Polar Capital Holdings PLC Pacira Bio Sciences, Inc. Transaction History
Polar Capital Holdings PLC
- $17.4 Billion
- Q2 2025
A detailed history of Polar Capital Holdings PLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Polar Capital Holdings PLC holds 910,455 shares of PCRX stock, worth $22.6 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
910,455Holding current value
$22.6 Million% of portfolio
0.12%Shares
8 transactions
Others Institutions Holding PCRX
# of Institutions
256Shares Held
51.5MCall Options Held
289KPut Options Held
130K-
Black Rock Inc. New York, NY8.01MShares$199 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.41MShares$134 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.4MShares$59.4 Million0.08% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.25MShares$55.9 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.15MShares$53.4 Million0.01% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.14B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...